In vitro stent lumen visualisation of various common and newly developed femoral artery stents using MR angiography at 1.5 and 3 tesla.

OBJECTIVES: To evaluate stent lumen assessment of various commonly used and newly developed stents for the superficial femoral artery (SFA) using MR angiography (MRA) at 1.5 and 3 T. METHODS: Eleven nitinol stents and one cobalt-chromium stent were compared regarding stent lumen visualisation using a common three-dimensional MRA sequence. Maximum visible stent lumen width and contrast ratio were analysed in three representative slices for each stent type. A scoring system for lumen visualisation was applied. RESULTS: Nitinol stents showed significantly better performance than the cobalt chromium stent (P < 0.05) at 1.5 and 3 T. Maximum visible stent lumen ranged between 43.4 and 95.5 %, contrast ratio between 7.2 and 110.6 %. Regarding both field strengths, seven of the nitinol stents were classified as "suitable". Three nitinol stents were "limited", and one nitinol stent and the cobalt chromium stent were "not suitable". CONCLUSIONS: Intraluminal loss of signal and artefacts of most of the SFA stents do not markedly limit assessment of stent lumen by MRA at 1.5 and 3 T. MRA can thus be considered a valid technique for detection of relevant in-stent restenosis. Applied field strength does not strongly influence stent lumen assessment in general, but proper choice of field strength might be helpful.

New concepts on formation of Brunn's nests and cysts in urinary tract mucosa.

To the present time, Brunn's nests have been conceived as being the result of pinching off of epithelial nests from urothelial buds. Mucosal cysts were considered to originate from Brunn's nests. In the present study, it was observed that under the influence of a strong stimulus of repair, the urothelial cells in the proximity of the focus of repair undergo numerous mitoses. The underlying connective tissue becomes loose, isolated cells of the lining urothelium "drop off" into the lamina propria in which they migrate as in a culture medium. There they multiply and form nests of cells at a distance from the lining urothelium. These migrating cells frequently have an early tendency to become arranged into cysts. Thus, during this process of repair urothelial cells behave temporarily as malignant cells.

Estimation of radiation exposure of prospectively triggered 128-slice computed tomography coronary angiography.

PURPOSE: To estimate the effective dose of prospectively triggered computed tomography coronary angiography (CTCA) in step-and-shoot (SAS) mode, depending on the tube current and tube voltage modulation. MATERIALS AND METHODS: For dose measurements, an Alderson-Rando-phantom equipped with thermoluminescent dosimeters was used. The effective dose was calculated according to ICRP 103. Exposure was performed on a 128-slice single source scanner providing a collimation of 128 × 0.6 mm and a rotation time of 0.38 seconds. CTCA in the SAS mode was acquired with variation of the tube current (160, 240, 320 mAs) and tube voltage (100, 120, 140 kV) at a simulated heart rate of 60 beats per minute and a scan range of 13.5 cm. RESULTS: Depending on gender, tube current and tube voltage, the effective dose of a CTCA in SAS mode varies from 2.8 to 10.8 mSv. Due to breast tissue in the primary scan range, exposure in the case of females showed an increase of up to 60.0 ± .4% compared to males. The dose reduction achieved by a reduction of tube current showed a significant positive, linear correlation to effective dose with a possible decrease in the effective dose of up to 60.4% (r = 0.998; p = 0.044). Disproportionately high, the estimated effective dose can be reduced by using a lower tube voltage with a dose reduction of up to 52.4%. CONCLUSION: Further substantial dose reduction of low-dose CTCA in SAS mode can be achieved by adapting the tube current and tube voltage and should be implemented in the clinical routine, i. e. adapting those protocol parameters to patient body weight.

Prostatic cancer revisited.

Thirty patients with prostatic carcinoma treated for varying lengths of time by radiation or endocrine therapy alone and in combination underwent staging and biospy of the prostate 3 years ago. Survival data for these patients have been correlated with the clinical and histologic findings of 3 years ago. A negative biopsy was associated with a better prognosis than a positive one and clinical rectal examination of the treated prostate was a poor index of cancer control. The group of patients treated with a combination of endocrine and radiation therapy was associated with the highest proportion of negative biopsies.